[PMH73] Retrospective analysis of the impact of persistence on health care charges among opioid-dependent patients treated with buprenorphine/naloxone using an insurance database in the United States

[PMH73] Retrospective analysis of the impact of persistence on health care charges among opioid-dependent patients treated with buprenorphine/naloxone using an insurance database in the United States

2011 Value in health

Zah, V. | Aballea, S. | Guelfucci, F. | Clay, E. | Baxter, T. | Volume: 14, Issue: 3, Pages: A199, analysis, database analysis, Retrospective Studies, United States,

Buprenorphine/naloxone (Suboxone®, Reckitt-Benckiser) is recommended for treating opiate addiction. Clinical guidelines do not specify the minimum duration of treatment required to achieve long-term remission. This study evaluated the impact of persistence on resource utilisation and healthcare charges.